Company: INGN
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0000950170-25-045737
Chunk: 4

Company: Inogen Inc
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 4
---
 or about March 27, 2025 in connection with the solicitation of proxies on behalf of the Board.

How do I get electronic access to the proxy materials?

The notice of annual meeting, proxy statement, and Annual Report are available by visiting www.proxyvote.com and typing in the control number as set forth (i) on the proxy card (for stockholders of record), or (ii) on the voting instruction form (for individuals who hold shares through a broker, bank, trustee, or nominee).

<div align='center'>-1-</div>

What information is contained in these materials?

The information included in this proxy statement relates to the proposals to be voted on at the Annual Meeting, the voting process, the compensation of our most highly paid executive officers and our directors, and certain other required information. Inogen’s Annual Report, which includes our audited financial statements, is being made available along with this proxy statement.

What proposals will be voted on at the Annual Meeting?

The proposals scheduled to be voted on at the Annual Meeting include:

the election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified;

a proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;

a proposal to approve, on an advisory and non-binding basis, the compensation of our named executive officers for our fiscal year ended December 31, 2024 as described in this proxy statement;

a proposal to approve the Amended and Restated 2023 Equity Incentive Plan; and

any other business that may properly come before the meeting.

How does our Board recommend that I vote?

Our Board recommends that you vote:

FOR the election of each of the three directors nominated by our Board and named in this proxy statement as Class II directors to serve for a three-year term;

FOR the ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;

FOR the approval, on an advisory and non-binding basis, of the compensation of our named executive officers for our fiscal year ended December 31, 2024 as described in this proxy statement; and

FOR the approval of the Amended and Restated 2023 Equity Incentive Plan.

Will there be any other items of business on the agenda?

If any other items of business or other matters are